Panagora Asset Management Inc Incyte Corp Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 82,370 shares of INCY stock, worth $5.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

82,370

Holding current value

$5.75 Million

% of portfolio

0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $4.72 Million - $5.65 Million	82,370 New	82,370 $5.44 Million
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $989,002 - $1.16 Million	17,489 Added 3.61%	501,933 $28.6 Million
Q4 2023 Feb 08, 2024	BUY	$52.16 - $64.19 $6.07 Million - $7.47 Million	116,345 Added 31.61%	484,444 $30.4 Million
Q3 2023 Oct 31, 2023	BUY	$57.77 - $65.93 $1.43 Million - $1.63 Million	24,778 Added 7.22%	368,099 $21.3 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $825,323 - $1.02 Million	-13,541 Reduced 3.79%	343,321 $21.4 Million
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $979,216 - $1.2 Million	-13,943 Reduced 3.76%	356,862 $25.8 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $5.9 Million - $7.39 Million	-87,822 Reduced 19.15%	370,805 $29.8 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $339,172 - $424,657	-5,125 Reduced 1.11%	458,627 $30.6 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $391,719 - $492,342	-5,919 Reduced 1.26%	463,752 $35.2 Million
Q1 2022 May 12, 2022	SELL	$66.02 - $79.71 $2.03 Million - $2.45 Million	-30,777 Reduced 6.15%	469,671 $37.3 Million
Q4 2021 Feb 10, 2022	BUY	$63.34 - $74.11 $16 Million - $18.7 Million	252,933 Added 102.19%	500,448 $36.7 Million
Q3 2021 Nov 10, 2021	SELL	$68.67 - $84.02 $138,988 - $170,056	-2,024 Reduced 0.81%	247,515 $17 Million
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $24.8 Million - $27.2 Million	-310,753 Reduced 55.46%	249,539 $21 Million
Q1 2021 May 12, 2021	SELL	$76.02 - $100.5 $2.2 Million - $2.91 Million	-28,926 Reduced 4.91%	560,292 $45.5 Million
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $3.69 Million - $4.46 Million	-45,650 Reduced 7.19%	589,218 $51.3 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $8.95 Million - $11.5 Million	-105,182 Reduced 14.21%	634,868 $57 Million
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $21.9 Million - $32.2 Million	-295,305 Reduced 28.52%	740,050 $76.9 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $6.98 Million - $9.5 Million	-110,548 Reduced 9.65%	1,035,355 $75.8 Million
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $11.3 Million - $14.8 Million	-154,990 Reduced 11.91%	1,145,903 $100 Million
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $12.7 Million - $15.1 Million	-174,773 Reduced 11.84%	1,300,893 $96.6 Million
Q2 2019 Aug 09, 2019	BUY	$73.52 - $88.7 $3.12 Million - $3.77 Million	42,504 Added 2.97%	1,475,666 $125 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $73.2 Million - $101 Million	1,150,999 Added 407.92%	1,433,162 $123 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $32.4 Million - $38.8 Million	-554,537 Reduced 66.28%	282,163 $17.9 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $12.6 Million - $15.2 Million	204,383 Added 32.32%	836,700 $57.8 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $12.2 Million - $16.8 Million	199,938 Added 46.24%	632,317 $42.4 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $15.1 Million - $18.4 Million	182,010 Added 72.7%	432,379 $36 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $4.86 Million - $6.05 Million	-51,904 Reduced 17.17%	250,369 $23.7 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $33 Million - $41.8 Million	302,273	302,273 $35.3 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Incyte Corp Transaction History